NU Skin Enterprises, Inc.
NUSNYSECIK 1021561Consumer discretionaryFiscal year ends Dec 31
Reports and events: 287 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-04-1406:02 ET | DEF 14A | Proxy statement | 0001140361-23-018326 |
| 2023-03-3016:28 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-23-014845 |
| 2023-02-1620:26 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001140361-23-007348 |
| 2023-02-1516:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-007254 |
| 2022-12-2217:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-22-046688 |
| 2022-11-0320:18 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001140361-22-039689 |
| 2022-11-0216:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-039595 |
| 2022-08-0519:15 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001140361-22-028236 |
| 2022-08-0416:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-028206 |
| 2022-07-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-025598 |
| 2022-06-1706:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-22-023342 |
| 2022-06-0606:09 ET | 8-K | 5.07 Shareholder vote results | 0001140361-22-021884 |
| 2022-06-0206:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-22-021546 |
| 2022-05-0520:53 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001140361-22-017690 |
| 2022-05-0416:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-017649 |
| 2022-04-1906:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-014934 |
| 2022-04-1216:05 ET | DEF 14A | Proxy statementPeriod 2022-06-02 | 0001140361-22-014127 |
| 2022-02-1607:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-005670 |
| 2022-02-1606:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001140361-22-005656 |
| 2022-01-0516:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-000661 |
| 2021-12-2916:10 ET | 8-K | 2.05 Exit or disposal costs; 2.06 Material impairments | 0001140361-21-043301 |
| 2021-11-0419:14 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001140361-21-036462 |
| 2021-11-0316:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-21-036423 |
| 2021-10-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-21-033451 |
| 2021-08-0916:08 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001140361-21-027549 |
| 2021-08-0521:31 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001140361-21-026999 |
| 2021-08-0416:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-21-026910 |
| 2021-06-2417:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-21-022209 |
| 2021-06-0316:55 ET | 8-K | 5.07 Shareholder vote results | 0001140361-21-019755 |
| 2021-05-0517:26 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001140361-21-015997 |
| 2021-05-0516:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-21-015947 |
| 2021-04-1906:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-013174 |
| 2021-04-1216:05 ET | DEF 14A | Proxy statementPeriod 2021-06-02 | 0001140361-21-012421 |
| 2021-02-1106:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-21-004213 |
| 2021-02-1106:04 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001140361-21-004212 |
| 2020-11-0520:33 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001140361-20-024586 |
| 2020-11-0416:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-20-024544 |
| 2020-10-2016:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-20-023403 |
| 2020-10-0218:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-20-022176 |
| 2020-08-0621:30 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001140361-20-017594 |
| 2020-08-0516:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-20-017563 |
| 2020-07-0116:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-20-015283 |
| 2020-06-0416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-20-013057 |
| 2020-05-0720:03 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001140361-20-010880 |
| 2020-05-0616:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-20-010835 |
| 2020-04-2106:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-20-009305 |
| 2020-04-1316:05 ET | DEF 14A | Proxy statementPeriod 2020-06-03 | 0001140361-20-008714 |
| 2020-03-1806:03 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-20-006136 |
| 2020-02-1321:00 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001140361-20-002997 |
| 2020-02-1216:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-20-002928 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 18:30 ET. Listed shows no prices and gives no investment advice.